Drawing for CRESCITA THERAPEUTICS INC.

USPTO serial 86882855

CRESCITA THERAPEUTICS INC.

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
WHITTAKER BROWN, TRACY
Law office
TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CRESCITA THERAPEUTICS INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gary P. Oakeson

GARY P. OAKESON THORPE NORTH & WESTERN LLP8180 S. 700 E., SUITE 350SANDY, UT 84070UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical research and development services; operation of a research and development company including the conducting of pre-clinical trials and clinical trials, the research and development of pharmaceuticals and drug products, and the commercialization of such products; research and development in the field of pharmaceuticals; research and development in the field of biotechnology; pharmaceutical and drug development; providing information about pharmaceutical and drug products; medical and scientific research; consulting services in the fields of pharmaceutical research and development, biotechnology research and development, pharmaceutical drug development, and medical and scientific research; and conducting pre-clinical and clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Apr 1, 2019MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 1, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 15, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 9, 2018DOCKASSIGNED TO EXAMINER—
Aug 22, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 22, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 22, 2018CNSISUSPENSION INQUIRY WRITTEN—
Feb 22, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 22, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Feb 22, 2018CNSLSUSPENSION LETTER WRITTEN—
Feb 22, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 22, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 21, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 15, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 15, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 15, 2018CNSISUSPENSION INQUIRY WRITTEN—
Aug 15, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 15, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Aug 15, 2017CNSLSUSPENSION LETTER WRITTEN—
Aug 15, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 15, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 20, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 20, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 20, 2017CNSISUSPENSION INQUIRY WRITTEN—
Jul 20, 2017DOCKASSIGNED TO EXAMINER—
Jun 22, 2017RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 22, 2017ALIEASSIGNED TO LIE—
Feb 1, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 5, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 5, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Dec 5, 2016CNSLSUSPENSION LETTER WRITTEN—
Nov 5, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 6, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 5, 2016DOCKASSIGNED TO EXAMINER—
Jan 28, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 27, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 25, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance